Skip to content
← Back to this collection

PUBLICATIONS · 30545780

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2019 Jan 19
First author
Dimopoulos MA

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2019 Jan 19;393(10168):204-205. doi: 10.1016/S0140-6736(18)33128-3.
    note
    Source null
    related pmid
    30545778
    relationship
    Comment in

Authors and identifiers

  1. name
    Dimopoulos MA
    type
    Author
  2. name
    Gay F
    type
    Author
  3. name
    Schjesvold F
    type
    Author
  4. name
    Beksac M
    type
    Author
  5. name
    Hajek R
    type
    Author
  6. name
    Weisel KC
    type
    Author
  7. name
    Goldschmidt H
    type
    Author
  8. name
    Maisnar V
    type
    Author
  9. name
    Moreau P
    type
    Author
  10. name
    Min CK
    type
    Author
  11. name
    Pluta A
    type
    Author
  12. name
    Chng WJ
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Dimopoulos MA
    type
    Author
  2. name
    Gay F
    type
    Author
  3. name
    Schjesvold F
    type
    Author
  4. name
    Beksac M
    type
    Author
  5. name
    Hajek R
    type
    Author
  6. name
    Weisel KC
    type
    Author
  7. name
    Goldschmidt H
    type
    Author
  8. name
    Maisnar V
    type
    Author
  9. name
    Moreau P
    type
    Author
  10. name
    Min CK
    type
    Author
  11. name
    Pluta A
    type
    Author
  12. name
    Chng WJ
    type
    Author
bibliography ids
  1. nci-bib-da75231a0984d782ea5c290e
book metadata
content sha256
e3ab9851ee51ecf471dc976378ac884bebdf83c215669021b99388ec2fe2d3c9
document type
citation
dois
  1. 10.1016/S0140-6736(18)33003-4
electronic publication date
display
2018 Dec 10
precision
day
year
2018
evidence scope
bibliographic_metadata_only
id
pubmed:30545780
immutable id
pubmed:30545780@e3ab9851ee51ecf471dc976378ac884bebdf83c215669021b99388ec2fe2d3c9
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
10168
name
Lancet (London, England)
nlm unique id
2985213R
pages
253-264
volume
393
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2019 Jan 19;393(10168):204-205. doi: 10.1016/S0140-6736(18)33128-3.
    note
    Source null
    related pmid
    30545778
    relationship
    Comment in
outcomes validated
false
pmid
30545780
provenance
batch id
438b2803888025c6cf56
provider
NCBI PubMed ESummary
record sha256
847c74db565c9127f5ac7f769a3c87eb90ae539fefae0a52a6f23ec08a9e3fa8
response sha256
0adf5ff07d3aa03a45feef5e4b7998e2ddea370eb9d1c6aa9134c5fd329767e6
retrieved at
2026-09-09T23:47:36.359220+00:00
publication date
display
2019 Jan 19
precision
day
year
2019
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/30545780/
title
Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial.

Preserved source evidence · Not medical advice